blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1615898

EP1615898 - 2-Aminopyrimidine derivatives and their medical use [Right-click to bookmark this link]
Former [2006/03]2-AMINOPYRIMIDINE DERIVATIVES AND THEIR MEDICAL USE
[2014/23]
StatusNo opposition filed within time limit
Status updated on  04.09.2015
Database last updated on 14.06.2024
Most recent event   Tooltip27.10.2017Lapse of the patent in a contracting state
New state(s): BE		published on 29.11.2017  [2017/48]
Applicant(s)For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IT  LI  LU  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
[2014/34]
Former [2006/29]For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IT  LI  LU  MC  NL  PL 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Former [2006/03]For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IT  LU  MC  NL  PL 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Inventor(s)01 / BOLLBUCK, Birgit
Bodenseestrasse 23
79576 Weil am Rhein / DE
02 / DENHOLM, Alastair@Novartis Horsham Research Ctre.
Wimblehurst Road
Horsham, West Sussex RH12 5AB / GB
03 / EDER, Jörg
Zwischen den Bächen 4
79618 Rheinfelden / DE
04 / HERSPERGER, René
Höhenweg 32
CH-4142 Münchenstein / CH
05 / JANSER, Philipp
Delsbergerallee 1
CH-4053 Basel / CH
06 / RÉVÉSZ, Lászlo
Ob dem Fichtenrain 7
CH-4106 Therwil / CH
07 / SCHLAPBACH, Achim
Hünerbergweg 8
79539 Lörrach / DE
08 / WÄLCHLI, Rudolf
St. Johanns-Vorstadt 90
CH-4056 Basel / CH
 [2014/34]
Former [2006/03]01 / BOLLBUCK, Birgit
Bodenseestrasse 23
79576 Weil am Rhein / DE
02 / DENHOLM, Alastair Novartis Horsham Research Ctre.
Wimblehurst Road
Horsham, West Sussex RH12 5AB / GB
03 / EDER, Jörg
Zwischen den Bächen 4
79618 Rheinfelden / DE
04 / HERSPERGER, René
Höhenweg 32
CH-4142 Münchenstein / CH
05 / JANSER, Philipp
Delsbergerallee 1
CH-4053 Basel / CH
06 / R V SZ, Lászlo
Ob dem Fichtenrain 7
CH-4106 Therwil / CH
07 / SCHLAPBACH, Achim
Hünerbergweg 8
79539 Lörrach / DE
08 / WÄLCHLI, Rudolf
St. Johanns-Vorstadt 90
CH-4056 Basel / CH
Representative(s)von Sprecher, Georg
Novartis Pharma AG
Lichtstrasse 35
4056 Basel / CH
[N/P]
Former [2014/44]Maucher Börjes Jenkins
Urachstrasse 23
79102 Freiburg i. Br. / DE
Former [2009/08]Patent- und Rechtsanwaltssozietät Maucher, Börjes & Kollegen
Urachstrasse 23
79102 Freiburg i. Br. / DE
Former [2006/03]de Weerd, Petrus G.W.
Novartis International AG Corporate Intellectual Property
4002 Basel / CH
Application number, filing date04726485.808.04.2004
[2014/44]
WO2004EP03819
Priority number, dateGB2003000846611.04.2003         Original published format: GB 0308466
[2006/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004089913
Date:21.10.2004
Language:EN
[2004/43]
Type: A1 Application with search report 
No.:EP1615898
Date:18.01.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 21.10.2004 takes the place of the publication of the European patent application.
[2006/03]
Type: B1 Patent specification 
No.:EP1615898
Date:29.10.2014
Language:EN
[2014/44]
Search report(s)International search report - published on:EP21.10.2004
ClassificationIPC:C07D239/42, C07D403/04, C07D403/10, C07D403/14, C07D409/04, C07D413/10, A61K31/506, A61P1/00, A61P11/00, A61P17/00, A61P19/00, A61P25/00, A61P35/00, A61P37/00
[2006/03]
CPC:
C07D239/42 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P11/08 (EP); A61P13/12 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P19/00 (EP);
A61P19/02 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P27/04 (EP); A61P27/06 (EP); A61P27/14 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P31/10 (EP); A61P31/18 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P43/00 (EP); A61P7/04 (EP); A61P7/06 (EP);
C07D403/04 (EP,US); C07D403/10 (EP,US); C07D403/14 (EP,US);
C07D409/04 (EP,US); C07D409/14 (EP,US); C07D413/10 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/03]
TitleGerman:2-Aminopyrimidinderivate und ihre medizinische Verwendung[2014/44]
English:2-Aminopyrimidine derivatives and their medical use[2014/44]
French:Dérivés de 2-aminopyrimidine et leur utilisation médicale[2014/44]
Former [2006/03]2-AMINOPYRIMIDINDERIVATE UND IHRE MEDIZINISCHE VERWENDUNG
Former [2006/03]2-AMINOPYRIMIDINE DERIVATIVES AND THEIR MEDICAL USE
Former [2006/03]DERIVES DE 2-AMINOPYRIMIDINE ET LEUR APPLICATION EN MEDECINE
Entry into regional phase11.11.2005National basic fee paid 
11.11.2005Designation fee(s) paid 
11.11.2005Examination fee paid 
Examination procedure23.10.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
11.11.2005Examination requested  [2006/03]
03.03.2006Despatch of a communication from the examining division (Time limit: M08)
06.11.2006Reply to a communication from the examining division
18.09.2008Despatch of a communication from the examining division (Time limit: M04)
15.01.2009Reply to a communication from the examining division
28.02.2012Despatch of a communication from the examining division (Time limit: M04)
19.06.2012Reply to a communication from the examining division
08.07.2013Despatch of a communication from the examining division (Time limit: M04)
30.10.2013Reply to a communication from the examining division
28.05.2014Communication of intention to grant the patent
22.09.2014Fee for grant paid
22.09.2014Fee for publishing/printing paid
22.09.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.03.2006
Opposition(s)30.07.2015No opposition filed within time limit [2015/41]
Fees paidRenewal fee
02.05.2006Renewal fee patent year 03
02.05.2007Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
16.04.2009Renewal fee patent year 06
25.03.2010Renewal fee patent year 07
12.04.2011Renewal fee patent year 08
30.03.2012Renewal fee patent year 09
12.04.2013Renewal fee patent year 10
25.03.2014Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.04.2004
AT29.10.2014
BE29.10.2014
BG29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
MC29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SI29.10.2014
SK29.10.2014
TR29.10.2014
GR30.01.2015
PT02.03.2015
IE08.04.2015
LU08.04.2015
CH30.04.2015
LI30.04.2015
[2017/46]
Former [2017/39]HU08.04.2004
AT29.10.2014
BG29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
MC29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SI29.10.2014
SK29.10.2014
TR29.10.2014
GR30.01.2015
PT02.03.2015
IE08.04.2015
LU08.04.2015
CH30.04.2015
LI30.04.2015
Former [2016/20]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
MC29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SI29.10.2014
SK29.10.2014
GR30.01.2015
PT02.03.2015
IE08.04.2015
LU08.04.2015
CH30.04.2015
LI30.04.2015
Former [2016/12]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
MC29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SI29.10.2014
SK29.10.2014
GR30.01.2015
PT02.03.2015
LU08.04.2015
CH30.04.2015
LI30.04.2015
Former [2016/06]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
MC29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SK29.10.2014
GR30.01.2015
PT02.03.2015
LU08.04.2015
CH30.04.2015
LI30.04.2015
Former [2016/01]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
MC29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SK29.10.2014
GR30.01.2015
PT02.03.2015
LU08.04.2015
Former [2015/52]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SK29.10.2014
GR30.01.2015
PT02.03.2015
LU08.04.2015
Former [2015/37]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
SK29.10.2014
GR30.01.2015
PT02.03.2015
Former [2015/36]AT29.10.2014
CY29.10.2014
CZ29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
NL29.10.2014
PL29.10.2014
RO29.10.2014
SE29.10.2014
GR30.01.2015
PT02.03.2015
Former [2015/35]AT29.10.2014
CY29.10.2014
DK29.10.2014
EE29.10.2014
FI29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
PT02.03.2015
Former [2015/34]AT29.10.2014
CY29.10.2014
DK29.10.2014
FI29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
PT02.03.2015
Former [2015/26]AT29.10.2014
CY29.10.2014
FI29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
PT02.03.2015
Former [2015/25]AT29.10.2014
FI29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
PT02.03.2015
Former [2015/24]FI29.10.2014
NL29.10.2014
PL29.10.2014
SE29.10.2014
GR30.01.2015
PT02.03.2015
Former [2015/23]FI29.10.2014
NL29.10.2014
PT02.03.2015
Former [2015/22]PT02.03.2015
Cited inInternational search[X]WO9640143  (SMITHKLINE BEECHAM CORP [US], et al) [X] 1,2,6-10 * page 4, formula (I) * * page 35, Scheme VII * * page 48, line 12 - line 19 * * Examples 7, 11, 13 *;
 [A]WO03024971  (PROCTER & GAMBLE [US]) [A] 1-10 * page 1, paragraph 3 * * page 2, formula * * page 62, paragraph 2 *
by applicantWO9640143
 WO9816227
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.